Dapagliflozin and Empagliflozin in Heart Failure with Reduced Ejection Fraction: A Retrospective Study.

MLA

Hao, Zhengyang, and Yanzhou Zhang. “Dapagliflozin and Empagliflozin in Heart Failure with Reduced Ejection Fraction: A Retrospective Study.” International Journal of General Medicine, vol. 15, July 2022, pp. 5915–18. EBSCOhost, https://doi.org/10.2147/IJGM.S366943.

APA

Hao, Z., & Zhang, Y. (2022). Dapagliflozin and Empagliflozin in Heart Failure with Reduced Ejection Fraction: A Retrospective Study. International Journal of General Medicine, 15, 5915–5918. https://doi.org/10.2147/IJGM.S366943

Chicago

Hao, Zhengyang, and Yanzhou Zhang. 2022. “Dapagliflozin and Empagliflozin in Heart Failure with Reduced Ejection Fraction: A Retrospective Study.” International Journal of General Medicine 15 (July): 5915–18. doi:10.2147/IJGM.S366943.